Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.
Severe weather warning in your area. Please stay indoors and stay safe. Read more
regimen
CRBPGEMC+PEMB
Cancer Type
Lung,
Non-Small Cell
Intent
Palliative
Regimen Category
Evidence-informed
Funding Program
New Drug Funding Program
Pembrolizumab - In Combination with Carboplatin and Paclitaxel for First-Line Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
Drugs in Regimen
QBP Type
PDRP prior authorization
Prior authorization is required for PDRP funding of this drug within this regimen
Regimen Monograph
Aug 2022
Patient Info Sheet
Please see Drugs Used for related Patient Information Sheets. Patient Information Sheets are not yet available for this regimen.
Last Updated: August 12, 2026
